Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
作者： C.-C Jenq , Y.-C. Tian , H.-H. Wu , P.-Y. Hsu , J.-Y. Huang
DOI: 10.1111/J.1742-1241.2006.01166.X
关键词: Pill 、 Iron deficiency 、 Surgery 、 Gastroenterology 、 Oral administration 、 Ferric 、 Anemia 、 Hemodialysis 、 Internal medicine 、 Hematocrit 、 Complication 、 Medicine
摘要: Anaemia is a common and serious complication in patients with end-stage renal disease. Iron therapy crucial managing anaemia maintenance of haemodialysis (HD) patients. This study investigated the efficacy both oral intravenous (i.v.) therapies, possible factors deleteriously affecting patient response to iron therapy. Forty on HD from single institution were enrolled this 6-month retrospective study. Group I (n = 20) received i.v. two ampoules atofen (ferric chloride hexahydrate 193.6 mg) per week for total 6 weeks (total dosage, 960 mg). II ferrous sulphate S.C. Tab (ferrous 324 one pill three times daily 63,000 Patients whose haematocrit (Hct) level increased at minimum 3% within period classified as responders. ferric (960 was more effective than (63,000 correcting deficiency. In group I, serum triglyceride (TG) levels significantly lower responding no response. II, high-sensitive C-reactive protein (hs-CRP) The treating Serum hs-CRP TG may be parameters predicting hyporesponsiveness respectively.
sci-hub.se 参考文章(34)
Tsuchihashi K, Shimamoto K, Nakata T, Nagao K, Ura N, Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease. Canadian Journal of Cardiology. ,vol. 13, pp. 747- 753 ,(1997)
Tian-Gu Hsiau, Po-Yaur Hsu, Chih-Wei Yang, Chun-Liang Lin, Ten-Hui Sun, Lan-Mei Huang, Chu-Chun Chien, Chun-Chen Yu, Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study. Journal of Nephrology. ,vol. 17, pp. 693- 700 ,(2004)
Ezzat K. Amine, D. M. Hegsted, Iron Deficiency Lipemia in the Rat and Chick The Journal of Nutrition. ,vol. 101, pp. 1575- 1582 ,(1971) , 10.1093/JN/101.11.1575
Richard M. Iammarino, Marvin Lewis, Lipemia in rodent iron-deficiency anemia. Journal of Laboratory and Clinical Medicine. ,vol. 78, pp. 546- 554 ,(1971) , 10.5555/URI:PII:0022214371900916
Adria Rothman Sherman, Helen A. Guthrie, Ira Wolinsky, Ihor M. Zulak, Iron Deficiency Hyperlipidemia in 18-Day-Old Rat Pups: Effects of Milk Lipids, Lipoprotein Lipase, and Triglyceride Synthesis The Journal of Nutrition. ,vol. 108, pp. 152- 162 ,(1978) , 10.1093/JN/108.1.152
Stephen C. Cunnane, Kelly R. McAdoo, Iron intake influences essential fatty acid and lipid composition of rat plasma and erythrocytes Journal of Nutrition. ,vol. 117, pp. 1514- 1519 ,(1987) , 10.1093/JN/117.9.1514
A HEATH, S FAIRWEATHERTAIT, Clinical implications of changes in the modern diet: iron intake, absorption and status. Best Practice & Research Clinical Haematology. ,vol. 15, pp. 225- 241 ,(2002) , 10.1053/BEHA.2002.0208
Ja-Liang Lin, Ming-Yang Chang, Dan-Tzu Tan, Mei-Ling Leu, Short-term small-dose intravenous iron trial to detect functional iron deficiency in dialysis Patients American Journal of Nephrology. ,vol. 21, pp. 91- 97 ,(2001) , 10.1159/000046230
Steven Fishbane, Warren Shapiro, Paula Dutka, Osvaldo F. Valenzuela, Jessy Faubert, A randomized trial of iron deficiency testing strategies in hemodialysis patients1 Kidney International. ,vol. 60, pp. 2406- 2411 ,(2001) , 10.1046/J.1523-1755.2001.00077.X
Joel D. Kopple, National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. American Journal of Kidney Diseases. ,vol. 37, ,(2001) , 10.1053/AJKD.2001.20748